EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Comparative efficacy and safety of modified BEAM and BEAM/BEAC as conditioning regimens for autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma

Xiao-Ning Wang iD, Yu-Qi Wang iD, Rui-Min Liu, Juan Ren, Hua-Chao Zhu, Peng-Cheng He

Cell Transplantation · 2025

DOI: 10.1177/09636897251383464 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cell Transplantation, 2025. Verfasst von Xiao-Ning Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Hematopoietic Stem Cell Transplantation, Lymphoma, Non-Hodgkin, Melphalan. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Medical Basic Clinical Integration Innovation Project of Xi’an Jiaotong University, the Key Research and National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study compared the efficacy and safety of the modified BEAM (mitoxantrone hydrochloride liposome replacing melphalan) versus BEAM/BEAC as a conditioning regimen for autologous hematopoietic stem cell transplantation (auto-HSCT) in patients with non-Hodgkin lymphoma (NHL). The data source for the modified BEAM regimen was obtained from a prospective, single-arm study (NCT05681403), while the BEAM/BEAC regimen was retrospectively collected from an electronic health record–derived external control group. Primary endpoint was the cumulative incidence of relapse (CIR). Eighty-three patients were included, with 34 in the modified BEAM group, 23 in the BEAM group, and 26 in the BEAC group. The median times were 10.5, 9.0, and 9.0 days for neutrophil engraftment, and 10.5, 10.0, and 10.0 days for platelet engraftment, respectively. Oral mucositis (14.7%, 21.7%, and 7.7%), nausea (8.8%, 17.4%, and 0.0%), and diarrhea (5.9%, 8.2%, and 0.0%) were the most common grade 3–4 non-hematologic toxicities in three groups. No treatment-related death was reported. Besides, no significant differences were observed in 2-year CIR (9.4%, 26.6%, and 23.6%), progression-free survival (90.6%, 73.4%, and 76.4%), and overall survival (97.1%, 87.0%, and 88.5%) rates among three groups (all P > 0.05). The modified BEAM conditioning regimen may have comparable efficacy and safety with the BEAM/BEAC regimen in treating patients with NHL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell TransplantationLymphoma, Non-HodgkinMelphalanTransplantation ConditioningAdultAgedFemaleHumansMaleMiddle AgedYoung AdultCytarabineProspective StudiesRetrospective StudiesTransplantation, AutologousTreatment OutcomeCarmustineEtoposide

Stichwörter der Autor:innen

BEAM/BEACautologous hematopoietic stem cell transplantationconditioning regimenmitoxantrone hydrochloride liposomenon-Hodgkin lymphoma

Substanzen

CytarabineMelphalanCarmustineEtoposide

Autor:innen und Institutionen

  • Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

ORCID-Profile: Xiao-Ning Wang, Yu-Qi Wang

Förderung

  • the Medical Basic Clinical Integration Innovation Project of Xi’an Jiaotong University
  • the Key Research and National Key R&D Program of China

Zitieren

APA

Wang, X. N., Wang, Y. Q., Liu, R. M., Ren, J., Zhu, H. C., & He, P. C. (2025). Comparative efficacy and safety of modified BEAM and BEAM/BEAC as conditioning regimens for autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma. Cell Transplantation. https://doi.org/10.1177/09636897251383464

Vancouver

Wang XN, Wang YQ, Liu RM, Ren J, Zhu HC, He PC. Comparative efficacy and safety of modified BEAM and BEAM/BEAC as conditioning regimens for autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma. Cell Transplantation. 2025. doi:10.1177/09636897251383464

BibTeX
@article{Wang2025,
  author = {Wang, Xiao-Ning and Wang, Yu-Qi and Liu, Rui-Min and Ren, Juan and Zhu, Hua-Chao and He, Peng-Cheng},
  title = {Comparative efficacy and safety of modified BEAM and BEAM/BEAC as conditioning regimens for autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma},
  journal = {Cell Transplantation},
  year = {2025},
  doi = {10.1177/09636897251383464}
}
Kostenlos starten →